Medical Countermeasures Emergent BioSolutions Secures $27 Million in International Orders for Critical Medical CountermeasuresGlobal Biodefense StaffMarch 18, 2025
Industry News Moderna Secures Contract with European Union for COVID-19 VaccinesGlobal Biodefense StaffJanuary 24, 2025
Medical Countermeasures Bolstering Pandemic Preparedness: HHS Funds Accelerated Development of H5N1 VaccineGlobal Biodefense StaffJanuary 17, 2025
Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes Industry News October 6, 2021 …
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA Industry News October 3, 2021 …
Soligenix COVID-19 Vaccine Demonstrates Efficacy in Non-Human Primates Industry News September 28, 2021 …
Aidar Health’s Rapid Patient Triage System Gains Federal Funding From BARDA Industry News September 27, 2021 …
Is it a Bacterial or Viral Infection? Novel MeMed Rapid Test Receives FDA Clearance Antimicrobial Resistance September 24, 2021 …
HHS Taps Draper to Develop Lung-on-a-Chip Technology to Study SARS-CoV-2 Biodetection September 23, 2021 …
LexaGene Enters into CRADA with DoD to Foster Biothreat Detection Capabilities Biodetection September 23, 2021 …
Navrogen Enters CRADA with USAMRIID to Test Small Molecule NK Cell Activators Against SARS-COV-2 Infection Industry News September 13, 2021 …
New Manufacturing Plant Gives Canada Domestic Production Capability for N95-Type Mask Filters Industry News July 4, 2021 …
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals Industry News April 15, 2021 …
OSU’s New Vaccine Candidate for COVID-19 Capitalizes on Measles Vaccine’s Successful History Industry News March 16, 2021 …
DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators Industry News March 2, 2021 …
Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses Industry News February 19, 2021 …
BioFactura Funded $13M Contract Option for Smallpox Biodefense Therapeutic Industry News February 19, 2021 …
Altimmune Poised to Begin Phase 1 Clinical Trial of Single-Dose Intranasal COVID-19 Vaccine Industry News November 25, 2020 …